AlphAIAlphAI — Financial news for AI agents
SEC EDGARSEP 101 min read$FTRE

Russell Carrie Elizabeth sold $4K of FTRE

Russell Carrie Elizabeth (Interim CAO) sold 246 shares of Fortrea Holdings Inc. (FTRE) at $16.85 on 2026-09-09.

Original reporting
SEC EDGAR · Russell Carrie Elizabeth
Published Sep 10, 2026, 8:08 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Sep 10, 2026, 8:38 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About AlphAI AI DeskScoring methodologyReport an issue
AlphAI market briefInsider activity
Primary signal
$FTRE
Neutral
high confidence
Mentioned
$FTRE
Relevance
3/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$FTRENeutralLow
01

Why it matters

The disclosed sale is modest and does not suggest a change in insider confidence.

02

Market read

Routine insider sale with minimal market impact.

03

What to watch

Potential upcoming corporate actions not yet announced could contextualize the sale.

Relevance 3/10Novelty 3/10Timing: filed Sep 10 2026

Background

Form 4 filings disclose insider transactions; investors track them for signals of confidence.

Company-level read

Ticker impact

$FTRENeutralHigh confidence
Context

Officer Russell Carrie Elizabeth sold 246 shares of Fortrea Holdings for $4,145, a direct insider sale disclosed via Form 4.

Expected impact

No significant price movement expected.

Evidence & confidence

The sale size is small relative to total shares and typical for insiders; market impact is negligible.

Market effects

Sector

None

Regional

None

Global

None

Counterpoint

What could challenge this read

Insider sales sometimes precede negative news; monitor for upcoming disclosures.

Key entities

  • Company
    Fortrea Holdings Inc.

    US-listed biotech firm (ticker FTRE).

  • Insider
    Russell Carrie Elizabeth

    Interim Chief Accounting Officer of Fortrea.

Read at source← All news

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

FTRE insider trading history →

Related articles

OCT 15
$FTREHigh

Why is Fortrea stock gaining today?

Fortrea Holdings Inc. (FTRE) stock rose 3.8% in pre-market trading after Deutsche Bank upgraded it to Buy with a $25 price target, citing confidence in its recovery. Zacks Research downgraded it to Strong Sell. The company's Q3 2026 earnings release is scheduled for October 29. The broader market is down due to inflation concerns, but FTRE's advance is notable.

investing.com1 min
OCT 6
$FTREHigh

Fortrea (FTRE) Stock Trades Up, Here Is Why

Fortrea Holdings (FTRE) stock rose 3.3% premarket after Barclays upgraded it to Overweight with a $38 price target, citing resilient bookings and margin recovery potential. The company reported Q3 revenue of $701.3M, beating estimates, and raised full-year revenue guidance to $2.73B midpoint. FTRE shares are up 34.1% YTD, reaching a 52-week high.

financialcontent.com2 min
OCT 6
High

Why is Fortrea stock surging today?

Fortrea Holdings Inc. stock rose 8.7% after Barclays upgraded it to Overweight and raised its price target to $23. The stock hit a 52-week high of $23.51 before closing at $22.95. Barclays cited optimism about the life sciences sector and Fortrea's near-term outlook. UBS also upgraded Fortrea to Hold, and the company has scheduled its Q3 2026 earnings release for October 29. The broader market was positive, with the S&P 500, Dow Jones, and Nasdaq each gaining 0.6%.

investing.com2 min